Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System
| Status: | Recruiting |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 21 - 95 |
| Updated: | 1/19/2019 |
| Start Date: | June 8, 2017 |
| End Date: | December 2020 |
| Contact: | Thomas Engels |
| Email: | Tengels@limflow.com |
| Phone: | 888-478-7705 |
Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System for Creating an AV Fistula for the Treatment of Critical Limb Ischemia
This pilot study will investigate the safety, effectiveness and feasibility of the LimFlow
Stent Graft System for creating an AV fistula in the Below The Knee (BTK) vascular system
using an endovascular, minimally invasive approach for the treatment of Critical Limb
Ischemia (CLI) in subjects ineligible for conventional endovascular or surgical limb salvage
procedures.
Stent Graft System for creating an AV fistula in the Below The Knee (BTK) vascular system
using an endovascular, minimally invasive approach for the treatment of Critical Limb
Ischemia (CLI) in subjects ineligible for conventional endovascular or surgical limb salvage
procedures.
Inclusion Criteria:
- Clinical diagnosis of critical limb ischemia with hemodynamic evidence of severely
diminished arterial inflow of the index limb and Rutherford Classification 5 r 6
- Reviewed and approved for eligibility by the Investigator and the Independent Safety
Committee (ISC)
Exclusion Criteria:
- Concomitant hepatic or renal insufficiency, thrombophlebitis, deep venous thrombus,
coagulation disorder
- Severe heart failure, recent MI or stroke
- Significant peripheral edema or infection that may preclude insertion of a prosthesis
or significantly impair wound healing
- Known allergies or contraindications to anti platelet therapy or device materials
- Immunodeficiency disorder or immunosuppressant therapy
- Life expectancy < 12 months
We found this trial at
7
sites
Click here to add this to my saved trials
Albuquerque, New Mexico 87102
Principal Investigator: Steve Henao, MD
Phone: 505-843-2802
Click here to add this to my saved trials
Cleveland, Ohio 44106
Principal Investigator: Medhi Shishehbor, MD
Phone: 216-844-3545
Click here to add this to my saved trials
Columbia, South Carolina 29203
Principal Investigator: Daniel Clair, MD
Phone: 803-434-4338
Click here to add this to my saved trials
New York, New York 10029
Principal Investigator: John Lantis, MD
Phone: 212-523-5915
Click here to add this to my saved trials
Washington, District of Columbia 20010
Principal Investigator: Nelson Bernardo, MD
Phone: 202-877-8475
Click here to add this to my saved trials
5950 Metro Way
Wyoming, Michigan 49519
Wyoming, Michigan 49519
Principal Investigator: Jihad Mustapha, MD
Phone: 616-252-7316
Click here to add this to my saved trials